3DExo+™ Matrix with Growth Factors (60bn Exosomes per vial)

60 Billion 3D-Cultured Exosomes | 1 mL Vial

Product Overview

3DExo+™ is a next-generation, cosmetic-grade exosome matrix derived from a proprietary 3D-cultured mesenchymal stem cell (MSC) secretome platform using Wharton’s Jelly–derived MSCs. Manufactured through controlled bioreactor systems, this advanced formulation delivers a high-density, cell-free matrix rich in extracellular vesicles, peptides, cytokines, and growth factors.

Designed exclusively for professional topical cosmetic and wellness support, 3DExo+™ provides a more physiologically relevant and biologically intact profile than conventional 2D-cultured or lyophilized exosome preparations. All biologics are manufactured to injectable quality standards, though they are labeled for topical and research use only unless used under appropriate physician discretion or applicable law (e.g., Right to Try).

Key Features

• 3D-Cultured MSC Secretome Platform
  Produced using advanced 3D bioreactor culture to enhance secretome and extracellular vesicle output.
• High-Density Exosome Content
  Each vial contains 60 billion exosomes, verified through analytical characterization.
• Fresh, Non-Lyophilized
  Never freeze-dried to preserve native membrane integrity and bioactive cargo.
• Cell-Free, Non-Viable Matrix
  Cosmetic-use only formulation with no live or viable cells.
• Xeno-Free & Serum-Free Manufacturing
  Human-derived process without animal components.
• Regulated Manufacturing Environment
  Produced in FDA-registered, ISO-aligned facilities with documented quality systems.

Intended Use

For topical cosmetic and wellness support applications only, including skin appearance enhancement and post-procedure cosmetic recovery protocols. All biologics are manufactured to injectable quality standards, though they are labeled for topical and research use only unless used under appropriate physician discretion or applicable law (e.g., Right to Try).

Quality, Testing & Compliance

• Cosmetic classification under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.)
• Manufactured under cosmetic GMP (ISO 22716-aligned)
• Each lot tested for:
  • Sterility (no growth)
  • Mycoplasma (negative)
  • Endotoxin (<0.005 EU/mL)
• Produced within documented quality and traceability systems

Ingredients listed per INCI standards (21 CFR 701).

Why Clinics Choose 3DExo+™

Clinics seeking higher biological fidelity, consistency, and cosmetic-grade integrity choose 3DExo+™ over conventional exosome serums. Our non-lyophilized, 3D-cultured platform prioritizes biologic preservation over logistics shortcuts—supporting predictable handling and premium cosmetic outcomes.